Stanford Autoimmune & Allergy Supergroup (SAAS)
Sponsored by the Institute for Immunity, Transplantation, and Infection (ITI)
Autoimmune and allergic diseases continue to have a significant impact upon human health. While important strides have been made in the treatment of these conditions, many questions still remain regarding how these diseases develop. And while in some cases there are therapeutic treatments that reduce symptoms, none of them are curative. And that is where the SAAS comes in!

New SAAS Request for Proposals

The Institute for Immunity, Transplantation and Infection (ITI) at Stanford University is pleased to announce a call for proposals for seed grant funding to support groundbreaking studies in the general areas of Autoimmunity and Allergy. We specifically want to support collaborative and interdisciplinary grant applications with either a basic or translational focus to advance our understanding of allergies or autoimmune diseases, including “orphan” diseases such as Lyme or ME/CFS that are not classically defined as autoimmune diseases. We particularly wish to encourage proposals to address pressing issues in Rheumatoid Arthritis, Multiple Sclerosis, Diabetes Type I, Connective Tissue Diseases (CTDs) such as Lupus (SLE), Celiac disease and other food allergies, inflammatory bowel disease (IBD), the roles of infection in autoimmune disease, and mechanisms of transplantation tolerance.

Awards will be made for $100,000 - $200,000 in total over two years in direct costs.

NEW EXTENDED DEADLINE FOR APPLICATIONS IS for applications is THURSDAY, JULY 7, 2022.